Conditions: Human Immunodeficiency Virus (HIV) Infections
Keywords: HIV-Infected Patients Evidencing Virologic Suppression
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 61
Healthy volunteers: no

Brief summary:
The main purpose is to explore whether atazanavir/ritonavir (ATV/RTV) single enhanced protease inhibitor therapy can maintain virologic suppression without a marked increase in virologic failure.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Atazanavir + Ritonavir
Intervention descriptions: intervention 1: Capsules, Oral, ATV 300mg + RTV 100mg, once daily, 96 weeks

Protocol document: